Chloroquine is a zinc ionophore

Jing Xue, Amanda Moyer, Bing Peng, Jinchang Wu, Bethany N Hannafon, Wei-Qun Ding, Jing Xue, Amanda Moyer, Bing Peng, Jinchang Wu, Bethany N Hannafon, Wei-Qun Ding

Abstract

Chloroquine is an established antimalarial agent that has been recently tested in clinical trials for its anticancer activity. The favorable effect of chloroquine appears to be due to its ability to sensitize cancerous cells to chemotherapy, radiation therapy, and induce apoptosis. The present study investigated the interaction of zinc ions with chloroquine in a human ovarian cancer cell line (A2780). Chloroquine enhanced zinc uptake by A2780 cells in a concentration-dependent manner, as assayed using a fluorescent zinc probe. This enhancement was attenuated by TPEN, a high affinity metal-binding compound, indicating the specificity of the zinc uptake. Furthermore, addition of copper or iron ions had no effect on chloroquine-induced zinc uptake. Fluorescent microscopic examination of intracellular zinc distribution demonstrated that free zinc ions are more concentrated in the lysosomes after addition of chloroquine, which is consistent with previous reports showing that chloroquine inhibits lysosome function. The combination of chloroquine with zinc enhanced chloroquine's cytotoxicity and induced apoptosis in A2780 cells. Thus chloroquine is a zinc ionophore, a property that may contribute to chloroquine's anticancer activity.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. The chemical structure of the…
Figure 1. The chemical structure of the chloroquine compound.
Chloroquine diphosphate salt was purchased from Sigma-Aldrich (San Louis, MO, C6628).
Figure 2. Effects of chloroquine on zinc…
Figure 2. Effects of chloroquine on zinc ion uptake.
A. A2780 cells were plated in a 96-well plate and treated with chloroquine (ChQ) alone or in combination with ZnCl2 at the indicated concentrations for 1 hour. The FluoZin-3 (1 µM) probe was added and the fluorescent signal was measured by excitation at 490/20 nm and emission at 528/38 nm. Data (n = 3, bars, SEM) are presented as a percentage of the highest fluorescence level detected. *, p<0.01, compared to cells without ChQ treatment, using One-way ANOVA followed by Bonferroni analysis. B. A2780 cells were plated in a 12-well plate and treated with ChQ and ZnCl2 at indicated concentrations for 1 hour. After addition of the FluoZin-3 probe, cells were examined under a fluorescent microscope by excitation at 490/20 nm and emission at 528/38 nm. Shown are representative images from three individual experiments.
Figure 3. Effects of CuCl 2 ,…
Figure 3. Effects of CuCl2, FeCl2, TPEN and Ca-EDTA on chloroquine-induced zinc ion uptake.
A. A2780 cells were plated in a 96-well plate and pretreated with TPEN or Ca-EDTA for 15 min prior to addition of chloroquine (ChQ) and ZnCl2 at the indicated concentrations for 1 hour. B. A2780 cells were plated in a 96-well plate and treated with ChQ alone or in combination with ZnCl2, CuCl2, or FeCl2 at the indicated concentrations for 1 hour. The FluoZin-3 AM (1 µM) probe was then added and fluorescent signal was recorded by excitation at 490/20 nm and emission at 528/38 nm. Data (n = 3, bars, SEM) are presented as a percentage of the highest fluorescence level detected. *, p<0.01, compared with the fluorescence detected in cells without ChQ treatment, using One-way ANOVA followed by Bonferroni analysis.
Figure 4. Intracellular zinc ion distribution in…
Figure 4. Intracellular zinc ion distribution in A2780 cells after chloroquine treatment.
A. A2780 cells were plated in a 6-well plate and treated with chloroquine (ChQ) and ZnCl2 at the indicated concentrations for 1 hour. After addition of the FluoZin-3 and LysoTracker probes, the cells were examined by confocal microscopy (excitation, 490/20 nm, emission, 528/38 nm for FluoZin-3; 555/28 nm, 617/73 nm for LysoTracker, respectively). Shown are representative images from three individual experiments. B. A2780 cells were plated in a 12-well plate and treated with clioquinol (CQ) and ZnCl2 at the indicated concentrations for 1 hour. Confocal images were captured as we previously described .
Figure 5. Effects of chloroquine plus zinc…
Figure 5. Effects of chloroquine plus zinc on caspase 3 activation and LC3B-II expression.
A2780 cells were treated with chloroquine (ChQ) or ZnCl2, alone or in combination at the indicated concentrations. Cell lysates were prepared and western blot was performed using primary antibodies against pro-caspase 3, LC3B-II, PARP, and β-actin. Shown are representative blots from three individual experiments.

References

    1. Krafts K, Hempelmann E, Skorska-Stania A (2012) From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy. Parasitol Res 111: 1–6.
    1. Lamoureux F, Zoubeidi A (2013) Dual inhibition of autophagy and the AKT pathway in prostate cancer. Autophagy 9: 1119–1120.
    1. Eldredge HB, Denittis A, Duhadaway JB, Chernick M, Metz R, et al. (2013) Concurrent Whole Brain Radiotherapy and Short-Course Chloroquine in Patients with Brain Metastases: A Pilot Trial. J Radiat Oncol 2.
    1. Goldberg SB, Supko JG, Neal JW, Muzikansky A, Digumarthy S, et al. (2012) A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancer. J Thorac Oncol 7: 1602–1608.
    1. Rojas-Puentes LL, Gonzalez-Pinedo M, Crismatt A, Ortega-Gomez A, Gambo-Vignolle C, et al. (2013) Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases. Radiat Oncol 8: 209.
    1. Zou Y, Ling YH, Sironi J, Schwartz EL, Perez-Soler R, et al. (2013) The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib. J Thorac Oncol 8: 693–702.
    1. Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O'Dwyer PJ (2013) Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin Cancer Res 19: 2995–3007.
    1. Zinn RL, Gardner EE, Dobromilskaya I, Murphy S, Marchionni L, et al. (2013) Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol Cancer 12: 16.
    1. Maycotte P, Aryal S, Cummings CT, Thorburn J, Morgan MJ, et al. (2012) Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8: 200–212.
    1. Kimura T, Takabatake Y, Takahashi A, Isaka Y (2013) Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res 73: 3–7.
    1. Bristol ML, Emery SM, Maycotte P, Thorburn A, Chakradeo S, et al. (2013) Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther 344: 544–552.
    1. Solomon VR, Lee H (2009) Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625: 220–233.
    1. Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140: 313–326.
    1. Lamoureux F, Thomas C, Crafter C, Kumano M, Zhang F, et al. (2013) Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363. Clin Cancer Res 19: 833–844.
    1. Yu H, Zhou Y, Lind SE, Ding WQ (2009) Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J 417: 133–139.
    1. Zheng J, Zhang XX, Yu H, Taggart JE, Ding WQ (2012) Zinc at cytotoxic concentrations affects posttranscriptional events of gene expression in cancer cells. Cell Physiol Biochem 29: 181–188.
    1. Ding WQ, Lind SE (2009) Metal ionophores - An emerging class of anticancer drugs. IUBMB Life 61: 1013–1018.
    1. Liuzzi JP, Yoo C (2013) Role of Zinc in the Regulation of Autophagy During Ethanol Exposure in Human Hepatoma Cells. Biol Trace Elem Res.
    1. Blackie MA (2013) Metal containing chloroquinolines: beyond hit and miss antimalarial efficacy to solid science. Mini Rev Med Chem 13: 597–606.
    1. Ding WQ, Liu B, Vaught JL, Yamauchi H, Lind SE (2005) Anticancer activity of the antibiotic clioquinol. Cancer Res 65: 3389–3395.
    1. Ding WQ, Liu B, Vaught JL, Palmiter RD, Lind SE (2006) Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol Cancer Ther 5: 1864–1872.
    1. Canzoniero LM, Manzerra P, Sheline CT, Choi DW (2003) Membrane-permeant chelators can attenuate Zn2+-induced cortical neuronal death. Neuropharmacology 45: 420–428.
    1. Ding WQ, Yu HJ, Lind SE (2008) Zinc-binding compounds induce cancer cell death via distinct modes of action. Cancer Lett 271: 251–259.
    1. Li M, Khambu B, Zhang H, Kang JH, Chen X, et al. (2013) Suppression of Lysosome Function Induces Autophagy via a Feedback Downregulation of MTORC1 Activity. J Biol Chem.
    1. Mercer E, Rekedal L, Garg R, Lu B, Massarotti EM, et al. (2012) Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals. Arthritis Res Ther 14: R135.
    1. Solomon DH, Massarotti E, Garg R, Liu J, Canning C, et al. (2011) Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. Jama 305: 2525–2531.
    1. Qin Y, Thomas D, Fontaine CP, Colvin RA (2008) Mechanisms of Zn2+ efflux in cultured cortical neurons. J Neurochem 107: 1304–1313.
    1. Aiba I, West AK, Sheline CT, Shuttleworth CW (2013) Intracellular dialysis disrupts Zn2+ dynamics and enables selective detection of Zn2+ influx in brain slice preparations. J Neurochem 125: 822–831.
    1. Baum L, Ng A (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J Alzheimers Dis 6: 367–377 discussion 443–369.
    1. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, et al. (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60: 1685–1691.
    1. Bincoletto C, Bechara A, Pereira GJ, Santos CP, Antunes F, et al. (2013) Interplay between apoptosis and autophagy, a challenging puzzle: New perspectives on antitumor chemotherapies. Chem Biol Interact 206: 279–288.

Source: PubMed

3
订阅